Case File
efta-efta00895067DOJ Data Set 9OtherDS9 Document EFTA00895067
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00895067
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
fr>
To: Jeffrey Epstein <[email protected]>
Subject: Re: Establishment Labs Deck
Date: Tue, 06 Feb 2018 18:20:18 +0000
The IPO numbers are based on the draft S-1 and due-diligence by Jeffries and BTIG that unfortunately they
asked I not share with anyone. It is a Costa Rica company. Most of the worlds implants are manufactured there
and therefor the knowledge and talent base is there. For example Allergen manufactures all of their global supply
there. I invested in 2015 at a 24M Pre and not looking to make a new investment.
The company is currently in final discussions with one of the largest PE funds out of NY for a round at 255M
Pre prior to the IPO and asked that I not share those documents with anyone until they close it out. Let me see
what else they are comfortable sharing and get back to you. The last round was done by Perceptive Advisors and
closed at roughly 200M post money.
I think
was trying to give you an idea of her and our financial position, what I'm working on and get your
thoughts and advice on much of what is going on in our life. I have always welcomed your candid thoughts and
advice and continue to but it may be a better conversation when I have more info that I can share or if we sit
down together and review everything in its entirety.
I will put together a more complete picture and get back to you.
Thanks!
This message is directed to and is for the use of the above-noted addressee only, and its contents may be legally privileged or
confidential. if the reader of this message is not the intended recipient, you are hereby notified that any distribution, dissemination, or
copy of this message is strictly prohibited. If you have received this message in error, please delete it immediately and notify the sender.
This message is not intended to be an electronic signature nor to constitute an agreement of any kind under applicable law unless
otherwise expressly indicated hereon.
On Feb 6, 2018, at 12:36 PM, jeffrey E. <[email protected]> wrote:
when you say jeffries is still targeting ipo , based on documents? if so what , docs.
you told me building
factories you forgot to mention they are in costa rica.
I want to be constructive and helpful if i can
this is not something i would put 2 cents in. latin american. ? no numbers all hype. . it is a warning
just like th halo doc. pipeline numbers. ??! sign of silliness.
On Tue, Feb 6, 2018 at 12:23 PM,
Jeffrey, below is the deck on EL.R.)11r
taking the time.
> wrote:
Our primary investment thesis on EL was the very low complication rate compared to all competition.
Jeffries is still targeting something north of 300M for IPO.
Also would be curious your thoughts on HALO. It is another one of our investments at CPH and me
personally but much smaller investment for me given the risk level still in the business. They have secured
the first US Navy contract and close to closing the Qatar and Parliament in London contracts.
EFTA00895067
All the best,
This message is directed to and is for the use of the above-noted addressee only, and its contents may be legally privileged or
confidential. If the reader of this message is not the intended recipient, you are hereby notified that any distribution, dissemination,
or copy of this message is strictly prohibited. If you have received this message in error, please delete it immediately and notify the
sender. This message is not intended to be an electronic signature nor to constitute an agreement of any kind under applicable law
unless otherwise expressly indicated hereon.
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation®gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00895068
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.